Serum Connective Tissue Growth Factor in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Review Article
Hassan, B., Ahmed, H., El-Gebaly, S., Mahjoub, A. (2022). Serum Connective Tissue Growth Factor in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Review Article. EKB Journal Management System, 89(2), 6419-6421. doi: 10.21608/ejhm.2022.269984
Beshier Abdallah Hassan; Hanan Samir Ahmed; Sherief Mohammed El-Gebaly; Ahmed Fawzy Fahmy Mahjoub. "Serum Connective Tissue Growth Factor in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Review Article". EKB Journal Management System, 89, 2, 2022, 6419-6421. doi: 10.21608/ejhm.2022.269984
Hassan, B., Ahmed, H., El-Gebaly, S., Mahjoub, A. (2022). 'Serum Connective Tissue Growth Factor in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Review Article', EKB Journal Management System, 89(2), pp. 6419-6421. doi: 10.21608/ejhm.2022.269984
Hassan, B., Ahmed, H., El-Gebaly, S., Mahjoub, A. Serum Connective Tissue Growth Factor in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Review Article. EKB Journal Management System, 2022; 89(2): 6419-6421. doi: 10.21608/ejhm.2022.269984

Serum Connective Tissue Growth Factor in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Review Article

The Egyptian Journal of Hospital Medicine
Article 55, Volume 89, Issue 2, October 2022, Page 6419-6421  XML PDF (388.14 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2022.269984
View on SCiNiTO View on SCiNiTO
Authors
Beshier Abdallah Hassan; Hanan Samir Ahmed; Sherief Mohammed El-Gebaly; Ahmed Fawzy Fahmy Mahjoub
Abstract
Background: The significant pulmonary vascular resistance can result in right-sided heart failure, elevated pulmonary vascular resistance, and even mortality, a progressive condition known as pulmonary arterial hypertension (PAH), which also has a high mortality and morbidity rate.
Objectives: we aimed investigate plasma connective tissue growth factor (CTGF) levels in pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) (PAH-CHD) in children and the relationships of CTGF with hemodynamic parameters. 
Material and methods: A review of MEDLINE, Cochrane Library, ClinicalTrials.gov, indexed through 31 October 2022, utilizing the following searches: connective tissue growth factor OR/AND one of the following: Biomarker; Children; Congenital heart disease; Pulmonary arterial hypertension [MESH], was conducted. Additional studies were identified through review of references. English-language epidemiological studies, clinical studies, and case reports/series of connective tissue growth factor was included. The authors reached consensus regarding study inclusion after full-text review. The body of literature was assessed for bias qualitatively.
Conclusion: Children with PAH-CHD had considerably higher serumconnective tissue growth factor (CTGF) levels, which were inversely linked with oxygen saturation. The parameters of the echocardiograph and CTGF did not correlate. A possible diagnostic biomarker for PAH-CHD in children may be found in serum CTGF levels.
 
Keywords
Children's serum CTGF; Pulmonary arterial hypertension; heart disease
Statistics
Article View: 110
PDF Download: 235